Clinical Trials Logo

Thyroid Cancer Metastatic clinical trials

View clinical trials related to Thyroid Cancer Metastatic.

Filter by:
  • None
  • Page 1

NCT ID: NCT03732495 Recruiting - Clinical trials for Thyroid Cancer Metastatic

Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas

LENVOS
Start date: July 26, 2019
Phase: Phase 2
Study type: Interventional

This study evaluates the combination of lenvatinib with denosumab in bone-predominant metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas. All patients will receive this combination of treatments.